These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Endothelin-A receptor inhibition after cardiopulmonary bypass: cytokines and receptor activation. Ford RL; Mains IM; Hilton EJ; Reeves ST; Stroud RE; Crawford FA; Ikonomidis JS; Spinale FG Ann Thorac Surg; 2008 Nov; 86(5):1576-83. PubMed ID: 19049753 [TBL] [Abstract][Full Text] [Related]
5. Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Girgis RE; Frost AE; Hill NS; Horn EM; Langleben D; McLaughlin VV; Oudiz RJ; Robbins IM; Seibold JR; Shapiro S; Tapson VF; Barst RJ Ann Rheum Dis; 2007 Nov; 66(11):1467-72. PubMed ID: 17472992 [TBL] [Abstract][Full Text] [Related]
6. Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan. Ooi H; Colucci WS; Givertz MM Circulation; 2002 Sep; 106(13):1618-21. PubMed ID: 12270852 [TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary bypass decreases pulmonary vascular resistance index after coronary artery bypass surgery. Toikkanen V; Rinne T; Huhtala H; Laurikka J; Porkkala H; Tarkka M; Mennander A Scand J Clin Lab Invest; 2014 Jan; 74(1):37-43. PubMed ID: 24266780 [TBL] [Abstract][Full Text] [Related]
8. [Effects of hyperoncotic cardiopulmonary bypass prime on extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery]. Jin X; Chen Z; Wang M; Lü W; Zhang W; Sun J Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(9):646-50. PubMed ID: 24842200 [TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial. Tripathi D; Therapondos G; Ferguson JW; Newby DE; Webb DJ; Hayes PC Gut; 2006 Sep; 55(9):1290-5. PubMed ID: 16434427 [TBL] [Abstract][Full Text] [Related]
10. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery? Eising GP; Niemeyer M; Günther T; Tassani P; Pfauder M; Schad H; Lange R Eur J Cardiothorac Surg; 2001 Aug; 20(2):282-9. PubMed ID: 11463545 [TBL] [Abstract][Full Text] [Related]
11. Temporal synthesis and release of endothelin within the systemic and myocardial circulation during and after cardiopulmonary bypass: relation to postoperative recovery. Dorman BH; Bond BR; Clair MJ; Walker CA; Pinosky ML; Reeves ST; Kratz JM; Zellner JL; Crumbley AJ; Multani MM; Spinale FG J Cardiothorac Vasc Anesth; 2000 Oct; 14(5):540-5. PubMed ID: 11052435 [TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized study of endothelin and postoperative recovery in off-pump versus conventional coronary artery bypass surgery. Dorman BH; Kratz JM; Multani MM; Baron R; Farrar E; Walton S; Payne K; Ikonomiois J; Reeves S; Mukherjee R; Spinale FG J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):25-9. PubMed ID: 14973794 [TBL] [Abstract][Full Text] [Related]
13. Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy men. MacIntyre IM; Dhaun N; Lilitkarntakul P; Melville V; Goddard J; Webb DJ Hypertension; 2010 Jun; 55(6):1406-11. PubMed ID: 20404221 [TBL] [Abstract][Full Text] [Related]
14. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617 [TBL] [Abstract][Full Text] [Related]
15. Post-cardiopulmonary bypass pulmonary hypertension in lambs with increased pulmonary blood flow. A role for endothelin 1. Reddy VM; Hendricks-Munoz KD; Rajasinghe HA; Petrossian E; Hanley FL; Fineman JR Circulation; 1997 Feb; 95(4):1054-61. PubMed ID: 9054770 [TBL] [Abstract][Full Text] [Related]